West Pharmaceutical Services Inc. | Large-cap | Healthcare
$246.99
1.60%
| West Pharmaceutical Stock Comparison:
West Pharmaceutical vs Intuitive SurgicalWest Pharmaceutical vs Becton, DickinsonWest Pharmaceutical vs AlconWest Pharmaceutical vs ResMedWest Pharmaceutical vs HologicWest Pharmaceutical vs S&P 500 | Market
TL;DR Income Statement Balance Sheet Cash Flow Key Ratios Peer Comparison

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Jun 2025

Income Metrics

Revenue 766.5M
Gross Profit 273.9M 35.73%
Operating Income 158.9M 20.73%
Net Income 131.8M 17.20%
EPS (Diluted) $1.82

Balance Sheet Metrics

Total Assets 4.0B
Total Liabilities 1.0B
Shareholders Equity 2.9B
Debt to Equity 0.35

Cash Flow Metrics

Operating Cash Flow 177.4M
Free Cash Flow 101.9M

Revenue & Profitability Trend

West Pharmaceutical Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i2.9B2.9B2.9B2.8B2.1B
Cost of Goods Sold i1.9B1.8B1.8B1.7B1.4B
Gross Profit i998.5M1.1B1.1B1.2B767.8M
Gross Margin % i34.5%38.3%39.4%41.5%35.8%
Operating Expenses
Research & Development i69.1M68.4M58.5M52.8M46.9M
Selling, General & Administrative i338.5M353.4M316.9M362.8M302.0M
Other Operating Expenses i-----
Total Operating Expenses i407.6M421.8M375.4M415.6M348.9M
Operating Income i590.9M707.4M760.8M760.2M418.9M
Operating Margin % i20.4%24.0%26.4%26.8%19.5%
Non-Operating Items
Interest Income i19.6M28.0M5.1M1.0M1.4M
Interest Expense i3.0M9.0M7.9M8.2M8.2M
Other Non-Operating Income-22.0M-28.4M-78.1M-4.1M-10.8M
Pre-tax Income i585.5M698.0M679.9M748.9M401.3M
Income Tax i107.5M122.3M114.7M107.2M72.5M
Effective Tax Rate % i18.4%17.5%16.9%14.3%18.1%
Net Income i492.7M593.4M585.9M661.8M346.2M
Net Margin % i17.0%20.1%20.3%23.4%16.1%
Key Metrics
EBITDA i764.0M875.7M835.8M885.6M530.6M
EPS (Basic) i$6.75$7.98$7.87$8.89$4.68
EPS (Diluted) i$6.69$7.88$7.73$8.67$4.57
Basic Shares Outstanding i7300000074300000744000007440000073900000
Diluted Shares Outstanding i7300000074300000744000007440000073900000

Income Statement Trend

West Pharmaceutical Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i484.6M853.9M894.3M762.6M615.5M
Short-term Investments i-----
Accounts Receivable i552.5M512.0M507.4M489.0M385.3M
Inventory i377.0M434.7M414.8M378.4M321.3M
Other Current Assets124.0M135.8M103.0M112.0M51.6M
Total Current Assets i1.5B1.9B1.9B1.7B1.4B
Non-Current Assets
Property, Plant & Equipment i274.0M263.7M258.9M208.8M199.5M
Goodwill i223.0M232.1M233.0M242.8M252.7M
Intangible Assets i10.8M15.1M18.4M23.0M30.5M
Long-term Investments-----
Other Non-Current Assets100.3M47.0M104.0M87.7M39.4M
Total Non-Current Assets i2.1B1.9B1.7B1.6B1.4B
Total Assets i3.6B3.8B3.6B3.3B2.8B
Liabilities
Current Liabilities
Accounts Payable i239.3M242.4M215.4M232.2M213.1M
Short-term Debt i17.9M151.7M18.2M53.5M12.4M
Current Portion of Long-term Debt-----
Other Current Liabilities57.4M39.5M32.1M29.3M31.4M
Total Current Liabilities i550.4M671.8M519.0M594.1M503.4M
Non-Current Liabilities
Long-term Debt i284.4M157.3M299.7M271.8M313.3M
Deferred Tax Liabilities i20.5M12.7M14.3M4.9M10.4M
Other Non-Current Liabilities62.2M58.5M51.6M38.2M31.8M
Total Non-Current Liabilities i410.7M276.7M412.9M384.3M435.9M
Total Liabilities i961.1M948.5M931.9M978.4M939.3M
Equity
Common Stock i18.8M18.8M18.8M18.8M18.8M
Retained Earnings i4.0B3.5B3.0B2.5B1.8B
Treasury Stock i1.1B637.6M370.9M229.5M167.7M
Other Equity-----
Total Shareholders Equity i2.7B2.9B2.7B2.3B1.9B
Key Metrics
Total Debt i302.3M309.0M317.9M325.3M325.7M
Working Capital i987.7M1.3B1.4B1.1B870.3M

Balance Sheet Composition

West Pharmaceutical Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i492.7M593.4M585.9M661.8M346.2M
Depreciation & Amortization i155.4M137.3M120.6M122.3M109.1M
Stock-Based Compensation i18.7M23.3M23.7M37.5M34.0M
Working Capital Changes i2.9M-20.4M-15.0M-198.1M-10.3M
Operating Cash Flow i661.5M772.1M697.7M579.2M472.3M
Investing Activities
Capital Expenditures i-----
Acquisitions i-00-2.2M0
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-1.7M-6.7M-3.6M300.0K-5.1M
Financing Activities
Share Repurchases i-566.6M-451.2M-222.2M-151.9M-121.4M
Dividends Paid i-59.1M-57.0M-54.1M-51.1M-48.1M
Debt Issuance i164.7M--00
Debt Repayment i-192.3M-2.3M-44.3M-2.2M-2.3M
Financing Cash Flow i-655.3M-510.6M-321.8M-205.2M-171.8M
Free Cash Flow i276.4M414.5M439.4M330.6M298.1M
Net Change in Cash i4.5M254.8M372.3M374.3M295.4M

Cash Flow Trend

West Pharmaceutical Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 36.91
Forward P/E 32.74
Price to Book 6.04
Price to Sales 5.98
PEG Ratio 1.87

Profitability Ratios

Profit Margin 16.48%
Operating Margin 20.87%
Return on Equity 17.72%
Return on Assets 10.53%

Financial Health

Current Ratio 2.78
Debt to Equity 10.52
Beta 1.05

Per Share Data

EPS (TTM) $6.67
Book Value per Share $40.74
Revenue per Share $40.83

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
wst17.7B36.916.0417.72%16.48%10.52
Intuitive Surgical 172.2B67.089.6516.04%28.51%0.00
Becton, Dickinson 56.3B35.892.216.18%7.41%75.93
Alcon 45.8B40.842.075.23%11.28%23.63
ResMed 41.7B29.936.9925.86%27.22%14.27
Hologic 15.1B28.143.1111.38%13.79%52.09

Financial data is updated regularly. All figures are in the company's reporting currency.